Back
DexCom Vs. Keros Therapeutics Industry Stock Comparison
Buy
53
DXCM
DexCom
Last Price:
113.52
Seasonality Move:
8.46%
Sell
25
KROS
Keros Therapeutics
Last Price:
45.47
Seasonality Move:
4.22%
Buy
53
DexCom (DXCM)
is a Buy
Is DexCom a Buy, Sell or Hold?
- The current DexCom [DXCM] share price is $110.31. The Score for DXCM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- DXCM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DXCM Stock Price Chart
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
DXCM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.56 | Sell |
| Relative Strength Index (14 RSI): | 30.26 | Sell |
| Chaikin Money Flow: | 112887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.31 - 125.53) | Sell |
| Bollinger Bands (100): | (118.15 - 134.99) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.91 | Sell |
| Relative Strength Index (14 RSI): | 36.74 | Sell |
| Chaikin Money Flow: | -120480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.18 - 50.06) | Sell |
| Bollinger Bands (100): | (50.42 - 64.92) | Sell |
DXCM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 114.57 | Sell |
| 20-day SMA: | 117.03 | Sell |
| 50-day SMA: | 124.83 | Sell |
| 200-day SMA: | 116.31 | Sell |
| 8-day EMA: | 114.12 | Sell |
| 20-day EMA: | 117.39 | Sell |
| 50-day EMA: | 122.43 | Sell |
| 200-day EMA: | 120.78 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.5 | Sell |
| 20-day SMA: | 47.57 | Sell |
| 50-day SMA: | 52.43 | Sell |
| 200-day SMA: | 46.94 | Sell |
| 8-day EMA: | 46.46 | Sell |
| 20-day EMA: | 48 | Sell |
| 50-day EMA: | 51.59 | Sell |
| 200-day EMA: | 50.14 | Sell |
DexCom Earnings Growth & DXCM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.34 per share, and an increase next year of $0.45 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
DexCom Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||